Molecular Mechanisms of Antibiotic Resistance in Uropathogenic Escherichia coli: A Narrative Review
Urogenital Tract Infection · 31.08.2025 · 20 (2) · 96-106
DOI: 10.14777/uti.2550018009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urogenital Tract Infection, erschienen am 31.08.2025. Verfasst von Nakjun Choi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Urinary tract infections (UTIs) are among the most prevalent bacterial infections worldwide, with uropathogenic Escherichia coli (UPEC) serving as the primary causative agent. Although antibiotic therapy remains the standard of care for UTI treatment, the increasing prevalence of antimicrobial resistance has substantially reduced the effectiveness of commonly prescribed antibiotics. Resistance to trimethoprim-sulfamethoxazole (TMP-SMX), β-lactams, and fluoroquinolones is particularly concerning, as these agents constitute the principal therapeutic options for UTIs. This review examines the molecular mechanisms underlying UPEC resistance to these three classes of antibiotics, including target site modifications, efflux pump overexpression, porin regulation, and enzymatic degradation. Furthermore, it explores how these resistance determinants contribute to the development of multidrug-resistant (MDR) UPEC strains, which demonstrate cross-resistance to multiple antibiotics and present significant challenges for clinical management. Novel therapeutic strategies, such as efflux pump inhibitors, bacteriophage therapy, and genomic-guided precision medicine, are under investigation as potential solutions to address the growing global burden of MDR UPEC, alongside alternative non-antibiotic treatments. This review aims to provide a comprehensive overview of the genetic and regulatory pathways driving antibiotic resistance in UPEC, offering insights that may guide the development of effective treatment strategies and help mitigate the ongoing spread of antimicrobial resistance.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Choi, N., Kim, D. U., & Lee, E. (2025). Molecular Mechanisms of Antibiotic Resistance in Uropathogenic Escherichia coli: A Narrative Review. Urogenital Tract Infection, 20(2), 96-106. https://doi.org/10.14777/uti.2550018009
Vancouver
Choi N, Kim DU, Lee E. Molecular Mechanisms of Antibiotic Resistance in Uropathogenic Escherichia coli: A Narrative Review. Urogenital Tract Infection. 2025;20(2):96-106. doi:10.14777/uti.2550018009
BibTeX
@article{Choi2025,
author = {Choi, Nakjun and Kim, Dong Uk and Lee, Eun-Jin},
title = {Molecular Mechanisms of Antibiotic Resistance in Uropathogenic Escherichia coli: A Narrative Review},
journal = {Urogenital Tract Infection},
year = {2025},
volume = {20},
number = {2},
pages = {96--106},
doi = {10.14777/uti.2550018009}
}
EUVIMED